RxDoctor Payments Data

Michael Catino, MD

Orthopaedic Surgery of the Spine · Denton, TXNPI 1336254523

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Medtronic at 29.3% of the total. Reporting peaked in 2019 at $681 and has fallen 71.6% since, to $193 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in TX, where the typical reported total is $12,726.

$1,326in general payments, 2019–2025

Across 58 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$389
  • Nevro Corp.$203
  • Boston Scientific$156
  • Saluda Medical Americas, Inc.$133
  • Abbott$94
  • Johnson & Johnson$85
  • plus $266 from 7 others

What the payments were for

  • Food & beverage$1,326100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,326 in reported general payments places this provider in the 20th percentile of 207 orthopaedic surgery of the spine providers in Texas.

See all orthopaedic surgery of the spine providers in Texas →

Medicare billing

Part B allowed, 2024
$301,150
Medicare patients
450
Services billed
2,378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin170$1,394
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen94$1,279
Acetaminophen-CodeineAcetaminophen With Codeine29$266
Pregabalin17$224
Meloxicam15$83
Tramadol Hcl13$41

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Denton

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →